| [1] |
Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease. Lancet, 2015, 385: 1460-1471.
|
| [2] |
Research Committee to establish diagnostic criteria and development of treatment for systemic IgG4-related sclerosing disease; Research Committee to establish a new clinical entity, IgG4-related multi-organ lymphoproliferative syndrome (IgG 4-MOLPS). Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Research Program of Intractable Disease provided by the Ministry of Health, Labor, and Welfare of Japan. Nippon Naika Gakkai Zasshi, 2012, 101:795-804.
|
| [3] |
Lang D, Zwerina J, Pieringer H, et al. IgG4-related disease: current challenges and future prospects. Ther Clin Risk Manag, 2016, 12: 189-199.
|
| [4] |
Stone JH, Brito-Zerón P, Bosch X, Ramos-Casals M. Diagnostic approach to the complexity of IgG4-related disease. Mayo Clin Proc, 2015, 90:927-939.
|
| [5] |
Umemura Takeji, Zen Yoh, Hamano Hideaki, et al. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis.Hepatology, 2007, 46: 463-471.
|
| [6] |
Peng Y, Li JQ, Zhang PP et al. Clinical outcomes and predictive relapse factors of IgG4-related disease following treatment: a long-term cohort study. J Intern Med, 2019, 286:542-552.
|
| [7] |
杨丽, 杨长青, IgG4相关肝胆胰疾病的发病机制和诊疗研究进展.胃肠病学, 2018, 23:277-282.
|
